Interpretive criteria for antimicrobial susceptibility testing of ceftiofur against bacteria associated with swine respiratory disease

MRL Pharmaceutical Services, Franklin, TN 37064, USA. Ceftiofur, an extended-spectrum cephalosporin, is active against a variety of animal pathogens, including organisms associated with swine respiratory disease. However, minimum inhibitory concentration (MIC) breakpoint and disk diffusion interpret...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of veterinary diagnostic investigation 1996-10, Vol.8 (4), p.464-468
Hauptverfasser: Burton, P.J. (MRL Pharmaceutical Services, Franklin, TN.), Thornsberry, C, Yee, Y.C, Watts, J.L, Yancey, R.J. Jr
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 468
container_issue 4
container_start_page 464
container_title Journal of veterinary diagnostic investigation
container_volume 8
creator Burton, P.J. (MRL Pharmaceutical Services, Franklin, TN.)
Thornsberry, C
Yee, Y.C
Watts, J.L
Yancey, R.J. Jr
description MRL Pharmaceutical Services, Franklin, TN 37064, USA. Ceftiofur, an extended-spectrum cephalosporin, is active against a variety of animal pathogens, including organisms associated with swine respiratory disease. However, minimum inhibitory concentration (MIC) breakpoint and disk diffusion interpretive criteria have not been established for swine pathogens. Susceptibility tests were performed by broth microdilution MIC and disk diffusion methods on 246 bacterial species that cause swine respiratory disease. Ceftiofur was active against Salmonella sp., Pasteurella multocida, Actinobacillus pleuropneumoniae, Streptococcus suis, and Escherichia coli but was not active against Bordetella bronchiseptica measured by MIC. Based on pharmacokinetic studies of ceftiofur in swine after a single intramuscular injection of 3 or 5 mg/kg body weight of ceftiofur and on the MIC and disk diffusion data, we recommend MIC breakpoints and disk diffusion distances, respectively, of
doi_str_mv 10.1177/104063879600800411
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_78604436</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sage_id>10.1177_104063879600800411</sage_id><sourcerecordid>78604436</sourcerecordid><originalsourceid>FETCH-LOGICAL-c431t-ec2cfb5d12703fd0ad971ed5384b2cd6d55909112ac6d1fd7f7257b5675bdcc13</originalsourceid><addsrcrecordid>eNp9kM1q3TAQhU1pSdO0LxAoaNPu3EjWn70sIU0CgS7arIWsH9-52JYrybncF8hzV8GXbgpZzQzznQPnVNUlwd8IkfKKYIYFbWUnMG4xZoS8qc5Jx2jNOirelr0A9QvxvvqQ0h5j3nBJzqqztuOUU3pePd_P2cUlugxPDpkI5QKNfIhIzxkmMDH0oEeU1mTckqGHEfIRZZcyzAMKHhnnMwS_FsWgYU4Z9dpsNjqlYEBnZ9EB8g6lA8wORZcWiDqHeEQWktPJfazeeT0m9-k0L6rHHze_r-_qh5-399ffH2rDKMm1M43xPbekkZh6i7XtJHGW05b1jbHCct7hjpBGG2GJt9LLErjnQvLeGkPoRfV1811i-LOWDGqCkmsc9ezCmpRsBWaMigI2G1jypxSdV0uEScejIli9lK_-L7-IPp_c135y9p_k1Hb5X23_pAen9mGNcwn7uuOXTbGDYXeA6FSa9DgW_0btnyy0iikmWOEuN87roPQQIanHX6UbLCShfwHIy6ZO</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>78604436</pqid></control><display><type>article</type><title>Interpretive criteria for antimicrobial susceptibility testing of ceftiofur against bacteria associated with swine respiratory disease</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Alma/SFX Local Collection</source><creator>Burton, P.J. (MRL Pharmaceutical Services, Franklin, TN.) ; Thornsberry, C ; Yee, Y.C ; Watts, J.L ; Yancey, R.J. Jr</creator><creatorcontrib>Burton, P.J. (MRL Pharmaceutical Services, Franklin, TN.) ; Thornsberry, C ; Yee, Y.C ; Watts, J.L ; Yancey, R.J. Jr</creatorcontrib><description>MRL Pharmaceutical Services, Franklin, TN 37064, USA. Ceftiofur, an extended-spectrum cephalosporin, is active against a variety of animal pathogens, including organisms associated with swine respiratory disease. However, minimum inhibitory concentration (MIC) breakpoint and disk diffusion interpretive criteria have not been established for swine pathogens. Susceptibility tests were performed by broth microdilution MIC and disk diffusion methods on 246 bacterial species that cause swine respiratory disease. Ceftiofur was active against Salmonella sp., Pasteurella multocida, Actinobacillus pleuropneumoniae, Streptococcus suis, and Escherichia coli but was not active against Bordetella bronchiseptica measured by MIC. Based on pharmacokinetic studies of ceftiofur in swine after a single intramuscular injection of 3 or 5 mg/kg body weight of ceftiofur and on the MIC and disk diffusion data, we recommend MIC breakpoints and disk diffusion distances, respectively, of</description><identifier>ISSN: 1040-6387</identifier><identifier>EISSN: 1943-4936</identifier><identifier>DOI: 10.1177/104063879600800411</identifier><identifier>PMID: 8953533</identifier><language>eng</language><publisher>Los Angeles, CA: J Vet Diagn Invest</publisher><subject>ACTINOBACILLUS PLEUROPNEUMONIAE ; Actinobacillus pleuropneumoniae - drug effects ; Animals ; BORDETELLA BRONCHISEPTICA ; Bordetella bronchiseptica - drug effects ; Cattle ; Cattle Diseases ; CEFALOSPORINAS ; CEPHALOSPORINE ; CEPHALOSPORINS ; Cephalosporins - administration &amp; dosage ; Cephalosporins - pharmacokinetics ; Cephalosporins - pharmacology ; CERDO ; ENFERMEDADES RESPIRATORIAS ; ESCHERICHIA COLI ; Escherichia coli - drug effects ; Injections, Intramuscular ; MALADIE RESPIRATOIRE ; Microbial Sensitivity Tests ; PASTEURELLA MULTOCIDA ; Pasteurella multocida - drug effects ; PORCIN ; RESPIRATORY DISEASES ; Respiratory Tract Infections - drug therapy ; Respiratory Tract Infections - microbiology ; Respiratory Tract Infections - veterinary ; SALMONELLA ; Salmonella - drug effects ; STREPTOCOCCUS SUIS ; Streptococcus suis - drug effects ; SWINE ; Swine Diseases</subject><ispartof>Journal of veterinary diagnostic investigation, 1996-10, Vol.8 (4), p.464-468</ispartof><rights>1996 American Association of Veterinary Laboratory Diagnosticians</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c431t-ec2cfb5d12703fd0ad971ed5384b2cd6d55909112ac6d1fd7f7257b5675bdcc13</citedby><cites>FETCH-LOGICAL-c431t-ec2cfb5d12703fd0ad971ed5384b2cd6d55909112ac6d1fd7f7257b5675bdcc13</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/8953533$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Burton, P.J. (MRL Pharmaceutical Services, Franklin, TN.)</creatorcontrib><creatorcontrib>Thornsberry, C</creatorcontrib><creatorcontrib>Yee, Y.C</creatorcontrib><creatorcontrib>Watts, J.L</creatorcontrib><creatorcontrib>Yancey, R.J. Jr</creatorcontrib><title>Interpretive criteria for antimicrobial susceptibility testing of ceftiofur against bacteria associated with swine respiratory disease</title><title>Journal of veterinary diagnostic investigation</title><addtitle>J Vet Diagn Invest</addtitle><description>MRL Pharmaceutical Services, Franklin, TN 37064, USA. Ceftiofur, an extended-spectrum cephalosporin, is active against a variety of animal pathogens, including organisms associated with swine respiratory disease. However, minimum inhibitory concentration (MIC) breakpoint and disk diffusion interpretive criteria have not been established for swine pathogens. Susceptibility tests were performed by broth microdilution MIC and disk diffusion methods on 246 bacterial species that cause swine respiratory disease. Ceftiofur was active against Salmonella sp., Pasteurella multocida, Actinobacillus pleuropneumoniae, Streptococcus suis, and Escherichia coli but was not active against Bordetella bronchiseptica measured by MIC. Based on pharmacokinetic studies of ceftiofur in swine after a single intramuscular injection of 3 or 5 mg/kg body weight of ceftiofur and on the MIC and disk diffusion data, we recommend MIC breakpoints and disk diffusion distances, respectively, of</description><subject>ACTINOBACILLUS PLEUROPNEUMONIAE</subject><subject>Actinobacillus pleuropneumoniae - drug effects</subject><subject>Animals</subject><subject>BORDETELLA BRONCHISEPTICA</subject><subject>Bordetella bronchiseptica - drug effects</subject><subject>Cattle</subject><subject>Cattle Diseases</subject><subject>CEFALOSPORINAS</subject><subject>CEPHALOSPORINE</subject><subject>CEPHALOSPORINS</subject><subject>Cephalosporins - administration &amp; dosage</subject><subject>Cephalosporins - pharmacokinetics</subject><subject>Cephalosporins - pharmacology</subject><subject>CERDO</subject><subject>ENFERMEDADES RESPIRATORIAS</subject><subject>ESCHERICHIA COLI</subject><subject>Escherichia coli - drug effects</subject><subject>Injections, Intramuscular</subject><subject>MALADIE RESPIRATOIRE</subject><subject>Microbial Sensitivity Tests</subject><subject>PASTEURELLA MULTOCIDA</subject><subject>Pasteurella multocida - drug effects</subject><subject>PORCIN</subject><subject>RESPIRATORY DISEASES</subject><subject>Respiratory Tract Infections - drug therapy</subject><subject>Respiratory Tract Infections - microbiology</subject><subject>Respiratory Tract Infections - veterinary</subject><subject>SALMONELLA</subject><subject>Salmonella - drug effects</subject><subject>STREPTOCOCCUS SUIS</subject><subject>Streptococcus suis - drug effects</subject><subject>SWINE</subject><subject>Swine Diseases</subject><issn>1040-6387</issn><issn>1943-4936</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1996</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kM1q3TAQhU1pSdO0LxAoaNPu3EjWn70sIU0CgS7arIWsH9-52JYrybncF8hzV8GXbgpZzQzznQPnVNUlwd8IkfKKYIYFbWUnMG4xZoS8qc5Jx2jNOirelr0A9QvxvvqQ0h5j3nBJzqqztuOUU3pePd_P2cUlugxPDpkI5QKNfIhIzxkmMDH0oEeU1mTckqGHEfIRZZcyzAMKHhnnMwS_FsWgYU4Z9dpsNjqlYEBnZ9EB8g6lA8wORZcWiDqHeEQWktPJfazeeT0m9-k0L6rHHze_r-_qh5-399ffH2rDKMm1M43xPbekkZh6i7XtJHGW05b1jbHCct7hjpBGG2GJt9LLErjnQvLeGkPoRfV1811i-LOWDGqCkmsc9ezCmpRsBWaMigI2G1jypxSdV0uEScejIli9lK_-L7-IPp_c135y9p_k1Hb5X23_pAen9mGNcwn7uuOXTbGDYXeA6FSa9DgW_0btnyy0iikmWOEuN87roPQQIanHX6UbLCShfwHIy6ZO</recordid><startdate>19961001</startdate><enddate>19961001</enddate><creator>Burton, P.J. (MRL Pharmaceutical Services, Franklin, TN.)</creator><creator>Thornsberry, C</creator><creator>Yee, Y.C</creator><creator>Watts, J.L</creator><creator>Yancey, R.J. Jr</creator><general>J Vet Diagn Invest</general><general>SAGE Publications</general><scope>FBQ</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>19961001</creationdate><title>Interpretive criteria for antimicrobial susceptibility testing of ceftiofur against bacteria associated with swine respiratory disease</title><author>Burton, P.J. (MRL Pharmaceutical Services, Franklin, TN.) ; Thornsberry, C ; Yee, Y.C ; Watts, J.L ; Yancey, R.J. Jr</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c431t-ec2cfb5d12703fd0ad971ed5384b2cd6d55909112ac6d1fd7f7257b5675bdcc13</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1996</creationdate><topic>ACTINOBACILLUS PLEUROPNEUMONIAE</topic><topic>Actinobacillus pleuropneumoniae - drug effects</topic><topic>Animals</topic><topic>BORDETELLA BRONCHISEPTICA</topic><topic>Bordetella bronchiseptica - drug effects</topic><topic>Cattle</topic><topic>Cattle Diseases</topic><topic>CEFALOSPORINAS</topic><topic>CEPHALOSPORINE</topic><topic>CEPHALOSPORINS</topic><topic>Cephalosporins - administration &amp; dosage</topic><topic>Cephalosporins - pharmacokinetics</topic><topic>Cephalosporins - pharmacology</topic><topic>CERDO</topic><topic>ENFERMEDADES RESPIRATORIAS</topic><topic>ESCHERICHIA COLI</topic><topic>Escherichia coli - drug effects</topic><topic>Injections, Intramuscular</topic><topic>MALADIE RESPIRATOIRE</topic><topic>Microbial Sensitivity Tests</topic><topic>PASTEURELLA MULTOCIDA</topic><topic>Pasteurella multocida - drug effects</topic><topic>PORCIN</topic><topic>RESPIRATORY DISEASES</topic><topic>Respiratory Tract Infections - drug therapy</topic><topic>Respiratory Tract Infections - microbiology</topic><topic>Respiratory Tract Infections - veterinary</topic><topic>SALMONELLA</topic><topic>Salmonella - drug effects</topic><topic>STREPTOCOCCUS SUIS</topic><topic>Streptococcus suis - drug effects</topic><topic>SWINE</topic><topic>Swine Diseases</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Burton, P.J. (MRL Pharmaceutical Services, Franklin, TN.)</creatorcontrib><creatorcontrib>Thornsberry, C</creatorcontrib><creatorcontrib>Yee, Y.C</creatorcontrib><creatorcontrib>Watts, J.L</creatorcontrib><creatorcontrib>Yancey, R.J. Jr</creatorcontrib><collection>AGRIS</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of veterinary diagnostic investigation</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Burton, P.J. (MRL Pharmaceutical Services, Franklin, TN.)</au><au>Thornsberry, C</au><au>Yee, Y.C</au><au>Watts, J.L</au><au>Yancey, R.J. Jr</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Interpretive criteria for antimicrobial susceptibility testing of ceftiofur against bacteria associated with swine respiratory disease</atitle><jtitle>Journal of veterinary diagnostic investigation</jtitle><addtitle>J Vet Diagn Invest</addtitle><date>1996-10-01</date><risdate>1996</risdate><volume>8</volume><issue>4</issue><spage>464</spage><epage>468</epage><pages>464-468</pages><issn>1040-6387</issn><eissn>1943-4936</eissn><abstract>MRL Pharmaceutical Services, Franklin, TN 37064, USA. Ceftiofur, an extended-spectrum cephalosporin, is active against a variety of animal pathogens, including organisms associated with swine respiratory disease. However, minimum inhibitory concentration (MIC) breakpoint and disk diffusion interpretive criteria have not been established for swine pathogens. Susceptibility tests were performed by broth microdilution MIC and disk diffusion methods on 246 bacterial species that cause swine respiratory disease. Ceftiofur was active against Salmonella sp., Pasteurella multocida, Actinobacillus pleuropneumoniae, Streptococcus suis, and Escherichia coli but was not active against Bordetella bronchiseptica measured by MIC. Based on pharmacokinetic studies of ceftiofur in swine after a single intramuscular injection of 3 or 5 mg/kg body weight of ceftiofur and on the MIC and disk diffusion data, we recommend MIC breakpoints and disk diffusion distances, respectively, of</abstract><cop>Los Angeles, CA</cop><pub>J Vet Diagn Invest</pub><pmid>8953533</pmid><doi>10.1177/104063879600800411</doi><tpages>5</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1040-6387
ispartof Journal of veterinary diagnostic investigation, 1996-10, Vol.8 (4), p.464-468
issn 1040-6387
1943-4936
language eng
recordid cdi_proquest_miscellaneous_78604436
source MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Alma/SFX Local Collection
subjects ACTINOBACILLUS PLEUROPNEUMONIAE
Actinobacillus pleuropneumoniae - drug effects
Animals
BORDETELLA BRONCHISEPTICA
Bordetella bronchiseptica - drug effects
Cattle
Cattle Diseases
CEFALOSPORINAS
CEPHALOSPORINE
CEPHALOSPORINS
Cephalosporins - administration & dosage
Cephalosporins - pharmacokinetics
Cephalosporins - pharmacology
CERDO
ENFERMEDADES RESPIRATORIAS
ESCHERICHIA COLI
Escherichia coli - drug effects
Injections, Intramuscular
MALADIE RESPIRATOIRE
Microbial Sensitivity Tests
PASTEURELLA MULTOCIDA
Pasteurella multocida - drug effects
PORCIN
RESPIRATORY DISEASES
Respiratory Tract Infections - drug therapy
Respiratory Tract Infections - microbiology
Respiratory Tract Infections - veterinary
SALMONELLA
Salmonella - drug effects
STREPTOCOCCUS SUIS
Streptococcus suis - drug effects
SWINE
Swine Diseases
title Interpretive criteria for antimicrobial susceptibility testing of ceftiofur against bacteria associated with swine respiratory disease
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T07%3A12%3A35IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Interpretive%20criteria%20for%20antimicrobial%20susceptibility%20testing%20of%20ceftiofur%20against%20bacteria%20associated%20with%20swine%20respiratory%20disease&rft.jtitle=Journal%20of%20veterinary%20diagnostic%20investigation&rft.au=Burton,%20P.J.%20(MRL%20Pharmaceutical%20Services,%20Franklin,%20TN.)&rft.date=1996-10-01&rft.volume=8&rft.issue=4&rft.spage=464&rft.epage=468&rft.pages=464-468&rft.issn=1040-6387&rft.eissn=1943-4936&rft_id=info:doi/10.1177/104063879600800411&rft_dat=%3Cproquest_cross%3E78604436%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=78604436&rft_id=info:pmid/8953533&rft_sage_id=10.1177_104063879600800411&rfr_iscdi=true